The peripheral myelin protein PMP22 gene has been described as a growth arr
est-specific gene gas3 and has been identified as disease gene of various d
emyelinating neuropathies. The gene consists of two highly conserved altern
ative noncoding 5'-exons 1a (CD25) and 1b (SR13), respectively. Differentia
l expression patterns of these transcripts in vivo and in vitro suggest a v
ery complex mode of PMP22 gene regulation, which cannot be explained merely
by transcriptional control, In fact, the PMP22 gene is regulated on differ
ent post-transcriptional levels. While reverse transcriptase polymerase cha
in reaction (RT-PCR) analyses revealed no alterations in stability for both
PMP22 transcripts in randomly growing Schwann cell cultures of rat sciatic
nerve for at least 8 hours, in serum-induced synchronized cultures of rest
ing cells we observed a specific cell cycle-regulated degradation of both t
ranscripts. We further prepared diverse PMP22/CAT fusion genes to study the
influence of the alternative 5'UTRs on PMP22 translation. Transient transf
ection of NIH3T3-fibroblasts and rat Schwann cells demonstrated that the al
ternative 5'UTRs: (CD25 and SR13) and the 3'UTR exert differential regulato
ry influences on the translation efficiency. J. Neurosci. Res. 55:164-177,
1999. (C) 1999 Wiley-Liss, Inc.